Serial evolution of TCR β chain transcript mobilization in HIV type-1-infected patients following vaccine immune stimulation and HAART interruption

AIDS Research and Human Retroviruses

Volumn 22, Issue 7, 2006, Pages 648-656

  Guillet, Marina ^a   Andrieu, Muriel ^b   Braudeau, Cécile ^a   Ruiz, Catherine ^a   Daniel, Nathalie ^b   Pallier, Annaïck ^a   Charmeteau, Bénédicte ^b   Veziers, Joelle ^a   Oden, Neal ^c   Bonilla, Nelly ^b   Brouard, Sophie ^a   Guillet, Jean Gérard ^b   Soulillou, Jean Paul ^a  

^a HÔTEL DIEU   (France)

^b INSERM   (France)

^c EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIPOPEPTIDE; NEF PROTEIN; T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ANTIGEN SPECIFICITY; ARTICLE; BLOOD SAMPLING; CASE REPORT; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; COMPLEMENTARITY DETERMINING REGION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; GENE TARGETING; HIGH RISK PATIENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MALE; PERIPHERAL LYMPHOCYTE; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; QUANTITATIVE ASSAY; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VACCINATION;

ADULT; AIDS VACCINES; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD8-POSITIVE T-LYMPHOCYTES; COMPLEMENTARITY DETERMINING REGIONS; GENE REARRANGEMENT, T-LYMPHOCYTE; GENES, T-CELL RECEPTOR BETA; HIV INFECTIONS; HIV-1; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MIDDLE AGED; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; REGRESSION ANALYSIS; SEQUENCE ANALYSIS, DNA;

EID: 33745963938     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.648     Document Type: Article

References (31)

1. Nemazee D: Receptor selection in B and T lymphocytes. Annu Rev Immunol 2000;18:19-51.
2. Brandt VL and Roth DB: A recombinase diversified: New functions of the RAG proteins. Curr Opin Immunol 2002;14:224-229.
3. Jorgensen JL, Esser U, Fazekas de St Groth B, Reay PA, and Davis MM: Mapping T-cell receptor-peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992;355:224-230.
4. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, and Kourilsky P: A direct estimate of the human alphabeta T cell receptor diversity. Science 1999;286:958-961.
5. Pannetier C, Even J, and Kourilsky P: T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-181.
6. Dong T, Stewart-Jones G, Chen N, Easterbrook P, Xu X, Papagno L, Appay V, Weekes M, Conlon C, Spina C, Little S, Screaton G, van der Merwe A, Richman D, McMichael AJ, Yvonne Jones E, and Rowland-Jones S: HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med 2004;200:1547-1557.
7. Sebille F, Gagne K, Guillet M, Degauque N, Pallier A, Brouard S, Vanhove B, Delsuc MA, and Soulillou JP: Direct recognition of foreign MHC determinants by naive T cells mobilizes specific Vbeta families without skewing of the complementarity-determining region 3 length distribution. J Immunol 2001;167:3082-3088.
8. Guillet M, Brouard S, Gagne K, Sebille F, Cuturi MC, Delsuc MA, and Soulillou JP: Different qualitative and quantitative regulation of Vbeta TCR transcripts during early acute allograft rejection and tolerance induction. J Immunol 2002;168:5088-5095.
9. Li TS, Tubiana R, Katlama C, Calvez A, Ait Mohand H, and Autran B: Long-lasting recovery in CD4 T-cell function and viral-load reduction after highly active antiretroviral therapy in advanced HIV-1 disease. Lancet 1998;351:1682-1686.
10. Kalams SA, Goulder PJ, Shea AK, Jones NG, Trocha AK, Ogg GS, and Walker BD: Levels of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte effector and memory responses decline after suppression of viremia with highly active antiretroviral therapy. J Virol 1999;73:6721-6728.
11. Soudeyns H, Campi G, Rizzardi GP, Lenge C, Demarest JF, Tambussi G, Lazzarin A, Kaufmann D, Casorati G, Corey L, and Pantaleo G: Initiation of antoretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor β chain repertoire and reduces the level of T-cell oligoclonality. Immunobiology 2000;95:1743-1751.
12. Ortiz GM, Nixon DF, Trkola A, Binley J, Jin X, Bonhoeffer S, Kuebler PJ, Donahoe SM, Demoitie MA, Kakimoto WM, Ketas T, Clas B, Heymann JJ, Zhang L, Cao Y, Hurley A, Moore JP, Ho DD, and Markowitz M: HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy. J Clin Invest 1999;104:R13-18.
13. Autran B, Carcelain G, Combadiere B, and Debre P: Therapeutic vaccines for chronic infections. Science 2004;305:205-208.
14. Gahery-Segard H, Pialoux G, Charmeteau B, Sermet S, Poncelet H, Raux M, Tartar A, Levy JP, Gras-Masse H, and Guillet JG: Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccine. J Virol 2000;74:1694-1703.
15. Brouard S, Dupont A, Giral M, Louis S, Lair D, Braudeau C, Degauque N, Moizant F, Pallier A, Ruiz C, Guillet M, Laplaud D, and Soulillou JP: Operationally tolerant and minimally immunosuppressed kidney recipients display strongly altered blood T-cell clonal regulation. Am J Transplant 2005;5:330-340.
16. Chomczynski P and Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
17. Gorochov G, Neumann AU, Kereveur A, Parizot C, Li T, Katlama C, Karmochkine M, Raguin G, Autran B, and Debre P: Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nat Med 1998;4:215-221.
18. Gagne K, Brouard S, Giral M, Sebille F, Moreau A, Guillet M, Bignon JD, Imbert MB, Cuturi MC, and Soulillou JP: Highly altered V beta repertoire of T cells infiltrating long-term rejected kidney allografts. J Immunol 2000;164:1553-1563.
19. Laplaud DA, Ruiz C, Wiertlewski S, Brouard S, Berthelot L, Guillet M, Melchior B, Degauque N, Edan G, Brachet P, Damier P, and Soulillou JP: Blood T-cell receptor beta chain transcriptome in multiple sclerosis. Characterization of the T cells with altered CDR3 length distribution. Brain 2004;127:981-995.
20. Degauque N, Schadendorf D, Brouard S, Guillet M, Sebille F, Hohn H, Pallier A, Ruiz C, Dupont A, Chapin S, Hofmann U, Maeurer M, and Soulillou JP: Blood T-cell Vbeta transcriptome in melanoma patients. Int J Cancer 2004;110:721-729.
21. Fitzgerald JE, Ricalton NS, Meyer AC, West SG, Kaplan H, Behrendt C, and Kotzin BL: Analysis of clonal CD8+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995;154:3538-3547.
22. Morley JK, Batliwalla FM, Hingorani R, and Gregersen PK: Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. J Immunol 1995;154:6182-6190.
23. Schwab R, Szabo P, Manavalan JS, Weksler ME, Posnett DN, Pannetier C, Kourilsky P, and Even J: Expanded CD4+ and CD8+ T cell clones in elderly humans. J Immunol 1997;158:4493-4499.
24. Prevost-Blondel A, Lengagne R, Letourneur F, Pannetier C, Gomard E, and Guillet JG: In vivo longitudinal analysis of a dominant TCR repertoire selected in human response to influenza virus. Virology 1997;233:93-104.
25. Maini MK, Gudgeon N, Wedderburn LR, Rickinson AB, and Beverley PC: Clonal expansions in acute EBV infection are detectable in the CD8 and not the CD4 subset and persist with a variable CD45 phenotype. J Immunol 2000;165:5729-5737.
26. Bitmansour AD, Waldrop SL, Pitcher CJ, Khatamzas E, Kern F, Maino VC, and Picker LJ: Clonotypic structure of the human CD4+ memory T cell responses to cytomegalovirus. J Immunol 2001;167:1151-1163.
27. Douillard P, Pannetier C, Josien R, Menoret S, Kourilsky P, Soulillou JP, and Cuturi MC: Donor-specific blood transfusion-induced tolerance in adult rats with a dominant TCR-Vbeta rearrangement in heart allografts. J Immunol 1996;157:1250-1260.
28. Pantaleo G, Demarest JF, Soudeyns H, Graziosi C, Denis F, Adelsberger JW, Borrow P, Saag MS, Shaw GM, Sekaly RP, and Fauci AS: Major expansion of CD8+ T cells with a predominant Vb usage during the primary immune response to HIV. Nature 1994;370:463-467.
29. Roglic M, Macphee RD, Duncan SR, Sattler FR, and Theofilopoulos AN: T cell receptor (TCR) BV gene repertoires and clonal expansions of CD4 cells in patients with HIV infections. Clin Exp Immunol 1997;107:21-30.
30. Pantaleo G, Soudeyns H, Demarest JF, Vaccarezza M, Graziosi C, Paolucci S, Daucher M, Cohen O, Denis F, Bidddison W, Sekaly RP, and Fauci AS: Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc Natl Acad Sci USA 1997;94:9848-9853.
31. Reiser JB, Gregoire C, Darnault C, Mosser T, Guimezanes A, Schmitt-Verhulst AM, Fontecilla-Camps JC, Mazza G, Malissen B, and Housset D: A T cell receptor CDR3beta loop undergoes conformational changes of unprecedented magnitude upon binding to a peptide/MHC class I complex. Immunity 2002;16:345-354.